Nicholas Matheos is an Investor at Maxim Group, whose known portfolio counts 9 companies.
Is Nicholas Matheos a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
Investor at Maxim Group, whose known portfolio counts 9 companies
- Alveo Technologies
- Abeona Therapeutics
- Contrafect
- Nacuity Pharmaceuticals
- Steakholder Foods
- BillMyParents
- Co-Diagnostics
- Edge Therapeutics
- Nano Labs
Investor Profile
The listing covers sectors Commerce, FinTech and Healthcare, and focus areas Family, Investment Banking and Public Markets. Startups operating in these areas may find Nicholas Matheos relevant.
Maxim Group appears in Growth, Late-Stage and Seed rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Nicholas Matheos is worth approaching.
Colleagues at Maxim Group
Thomas Custance
Investor
New York City, United States
Michael Rabinowitz
Chairman/CEO
Miami Beach, United States
Clifford A. Teller
Investor
Pelham, United States
Christopher Fiore
Investor
New York, United States
Bill Vitale
Investor
New York, United States
David Ranaudo
Managing Director
New York, United States
Sean Ash
Investor
New York, United States
Kyle Peterson
Investor
Massapequa, United States
Stephen Meszkat
Investor
New York, United States
Frequently asked questions
Who is Nicholas Matheos?
Nicholas Matheos is a venture debt investor based in New York, United States, listed as Investor at Maxim Group. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Nicholas Matheos personally.
What does Nicholas Matheos invest in?
Listed sectors include Commerce, FinTech and Healthcare; listed focus areas include Family, Investment Banking and Public Markets. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Nicholas Matheos invest at?
Maxim Group appears in Growth, Late-Stage and Seed rounds across its known deals, and Nicholas Matheos is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Nicholas Matheos listed at?
Nicholas Matheos is listed as Investor at Maxim Group. 9 other people in the database share a firm with Nicholas Matheos.
How do I contact Nicholas Matheos?
An email address and a LinkedIn page are on file for Nicholas Matheos. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal